MACQUARIE GROUP LTD - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2022$4,000
-60.0%
300
-33.5%
0.00%
Q2 2022$10,000
-60.0%
4510.0%0.00%
Q1 2022$25,000
-16.7%
4510.0%0.00%
Q4 2021$30,000
-21.1%
4510.0%0.00%
Q3 2021$38,000
-33.3%
4510.0%0.00%
Q2 2021$57,000
-98.4%
451
-98.6%
0.00%
-100.0%
Q1 2021$3,621,000
-17.0%
33,011
+8.0%
0.01%
-16.7%
Q4 2020$4,364,000
+7173.3%
30,564
+3512.8%
0.01%
Q3 2020$60,000
+1.7%
8460.0%0.00%
Q2 2020$59,0008460.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders